ZTF vs. VCT, SCPA, ESNT, TET, SYNT, IOF, HAYD, WCH, ITX, and DCTA
Should you be buying Zotefoams stock or one of its competitors? The main competitors of Zotefoams include Victrex (VCT), Scapa Group (SCPA), Essentra (ESNT), Treatt (TET), Synthomer (SYNT), Iofina (IOF), Haydale Graphene Industries (HAYD), Wilmcote Holdings plc (WCH.L) (WCH), Itaconix (ITX), and Directa Plus (DCTA). These companies are all part of the "specialty chemicals" industry.
Zotefoams vs. Its Competitors
Victrex (LON:VCT) and Zotefoams (LON:ZTF) are both small-cap basic materials companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, risk, analyst recommendations, profitability, valuation, dividends, institutional ownership and media sentiment.
In the previous week, Zotefoams had 2 more articles in the media than Victrex. MarketBeat recorded 2 mentions for Zotefoams and 0 mentions for Victrex. Zotefoams' average media sentiment score of 0.59 beat Victrex's score of 0.00 indicating that Zotefoams is being referred to more favorably in the news media.
Victrex currently has a consensus target price of GBX 822, suggesting a potential upside of 14.17%. Zotefoams has a consensus target price of GBX 540, suggesting a potential upside of 32.68%. Given Zotefoams' stronger consensus rating and higher possible upside, analysts plainly believe Zotefoams is more favorable than Victrex.
Victrex has a net margin of 10.81% compared to Zotefoams' net margin of 7.45%. Zotefoams' return on equity of 8.42% beat Victrex's return on equity.
75.5% of Victrex shares are owned by institutional investors. Comparatively, 29.0% of Zotefoams shares are owned by institutional investors. 4.1% of Victrex shares are owned by insiders. Comparatively, 4.5% of Zotefoams shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.
Victrex has higher revenue and earnings than Zotefoams. Victrex is trading at a lower price-to-earnings ratio than Zotefoams, indicating that it is currently the more affordable of the two stocks.
Victrex has a beta of 0.69, meaning that its stock price is 31% less volatile than the S&P 500. Comparatively, Zotefoams has a beta of 1.4, meaning that its stock price is 40% more volatile than the S&P 500.
Victrex pays an annual dividend of GBX 0.60 per share and has a dividend yield of 0.1%. Zotefoams pays an annual dividend of GBX 0.07 per share and has a dividend yield of 0.0%. Victrex pays out 175.7% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Zotefoams pays out 650.4% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Victrex is clearly the better dividend stock, given its higher yield and lower payout ratio.
Summary
Victrex and Zotefoams tied by winning 9 of the 18 factors compared between the two stocks.
Get Zotefoams News Delivered to You Automatically
Sign up to receive the latest news and ratings for ZTF and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding ZTF and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Zotefoams Competitors List
Related Companies and Tools
This page (LON:ZTF) was last updated on 9/6/2025 by MarketBeat.com Staff
